Joint Replacement Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 19.10 Billion |
| Market Size (2029) | USD 23.70 Billion |
| CAGR (2024 - 2029) | 4.60 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Joint Replacement Market Analysis
The Joint Replacement Market size is estimated at USD 19.10 billion in 2024, and is expected to reach USD 23.70 billion by 2029, growing at a CAGR of 4.60% during the forecast period (2024-2029).
The outbreak of COVID-19 adversely impacted the joint replacement market initially. For Instance, according to the NCBI research study published in April 2021, the first national lockdown on volume declined due to postponed joint replacement surgeries. The same source also stated that COVID-19 further hampered access to surgery and lengthened wait times for operations due to the rising waiting lists for joint replacement surgeries and the rising prevalence of osteoarthritis. However, with the ease of restriction and resumption of surgeries, the market started to gain traction and is expected to continue the upward trend over the forecast period.
The key factors driving the market growth include the increasing prevalence of osteoarthritis, the rising cases of orthopedic injury, and an increasing geriatric population. For Instance, according to arthritis statistics 2022 published by the SingleCare team in January 2022, 2021 more than 350 million people have arthritis globally. With the growing incidences of osteoarthritis, the demand for joint replacement is expected to increase, further boosting market growth. Furthermore, the increasing geriatric population and several orthopedic injuries are also expected to drive the joint replacement market over the forecast period. For Instance, according to the WHO report published in October 2022, in 2030, 1 in 6 people in the world will be over 60 years old. The same source also stated that the proportion of the population aged 60 and over will increase from 1 billion in 2020 to 1.4 billion. Furthermore, by 2050, the world's population of people aged 60 and over will be doubled. Since the geriatric population is more prone to orthopedic disorders, an increasing number of the geriatric population is expected to drive the market.
Furthermore, adopting various strategies, including partnerships, mergers, and acquisitions by key market players and product launches, is also expected to drive market growth. For Instance, in March 2023, Stryker launched Mako Total Knee 2.0, the next chapter in Mako SmartRobotics, at the AAOS 2023 Annual Meeting in Las Vegas. The Mako Total Knee 2.0 consists of a new intuitive design, customizable workflow, and other key features, including an innovative digital tensioner that allows surgeons to assess knee stability during total knee arthroplasty (TKA) surgery without additional instruments. Similarly, in January 2022, Symbios launched the ORIGIN CR Total Knee System, which completes the ORIGIN product line with both monoblock and modular versions for lower back support. The product will allow surgeons to perform a custom posterior cruciate ligament (PCL)--preserving knee replacement. Thus, considerable market growth is expected over the forecast period due to such factors.
However, the availability of alternatives and the high cost of the procedure are likely to restrain the market growth over the forecast period.
Joint Replacement Market Trends
Knee Replacement Segment is Expected to Hold a Significant Share Over the Forecast Period
Knee replacement surgery replaces parts of injured or worn-out knee joints. Surgery can help relieve pain and improve knee function. During surgery, damaged bones and cartilage are replaced with metal and plastic parts. The knee replacement segment is expected to witness major growth over the forecast period, owing to the rising burden of the geriatric population, the growing prevalence of osteoarthritis, and other chronic diseases like osteoporosis and diabetes.
Total knee arthroplasty (TKA), or total knee replacement, is one of the most frequently performed orthopedic procedures. Additionally, several studies have revealed an improvement in functionality after knee arthroplasty in the obese population. According to the Personalize Orthopaedics of the Palm Beaches, in November 2021, nearly 800,000 knee replacements were performed annually in the United States. According to estimates, knee replacement surgery is carried out about 800,000 times yearly in the United States alone, which keeps rising. Thus, increasing total knee replacement surgeries is expected to propel the segment growth.
Furthermore, product launches by the key market players and technological advancements are also expected to support the market growth. For Instance, in November 2021, OrthAlign, Inc., a privately held United States-based medical device and technology company, launched Lantern: the latest in smart, surgical technology for total and partial knee replacement surgery. Similarly, in July 2022, Enovis launched the Arvis wearable device with augmented reality visualization and an orthopedic navigation information system. The product is intended for the specific needs of hip and knee joint replacement surgery. Thus, such factors are expected to boost segment growth over the forecast period.
North America is Expected to Witness Considerable Growth Over the Forecast Period
The primary driving factors for the growth of the North American joint replacement market are the growing burden of osteoarthritis in the country, increasing injury cases, increasing prevalence of obesity, increasing product approvals, increasing investments, and key initiatives taken by the key market players. For instance, according to the CDC report published in October 2021, about 1 in 4 United States adults (23.7%) or about 58.5 million people have doctor-diagnosed arthritis. Moreover, according to the Centers for Disease Control and Prevention (CDC) updated in October 2021, about 1 in 4 United States adults (23.7%) or about 58.5 million people have doctor-diagnosed arthritis. Furthermore, according to the report published by Statistics Canada in September 2022, around 1.0% of Canadians had arthritis yearly, and around one out of every 100 adult Canadians had rheumatoid arthritis. Thus, such a high burden of orthopedic diseases is expected to positively impact the market in North America.
The growing product launches by the market players are one of the key factors propelling the market growth in the United States. For Instance, in January 2022, Smith+Nephew expanded the indications on its CORI Surgical System, a handheld robotic solution in total hip arthroplasty (THA). Smith+Nephew's RI. HIP NAVIGATION is designed to help maximize accuracy and reproducibility by delivering patient-specific component alignment for THA. Similarly, in August 2021, Zimmer Biomet Holdings, Inc. received United States Food and Drug Administration (FDA) 510(k) clearance of the ROSA Hip System for robotically-assisted direct anterior total hip replacement. Thus, owing to the factors above, the market is expected to witness a high growth rate in the United States over the forecast period.
Joint Replacement Industry Overview
The Joint Replacement market is highly competitive and consists of several major players. Companies like Stryker Corporation, Zimmer Biomet Holdings, Inc., Depuy Synthes (Johnson & Johnson), Smith & Nephew, and Wright Medical Group, among others, hold a substantial market share in the Joint Replacement market. Various developments have recently occurred in the market; market players are actively participating in new product launches, developments, and collaborations to expand their market share.
Joint Replacement Market Leaders
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Depuy Synthes (Johnson & Johnson)
Smith & Nephew
Wright Medical Group
*Disclaimer: Major Players sorted in no particular order
Joint Replacement Market News
- November 2022: Exactech announced that it had received 510(k) clearance from the US Food and Drug Administration to market the TriVerse primary knee system. The product is designed to meet surgical efficiency in hospitals and surgical centers alike. The TriVerse primary knee system offers crossed, anteriorly stabilized, and posteriorly stabilized designs.
- July 2022: Enovis launched its wearable Arvis, a device for augmented reality visualization and information systems that assist surgeons in hip and knee surgeries.
Joint Replacement Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Osteoarthritis
4.2.2 Rising Number of Cases of Orthopedic Injury
4.2.3 Increasing Geriatric Population
4.3 Market Restraints
4.3.1 Availability of Alternatives
4.3.2 Cost of the Procedure
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Procedure
5.1.1 Hip Replacement
5.1.2 Knee Replacement
5.1.3 Shoulder
5.1.4 Other Procedures
5.2 By Products
5.2.1 Implants
5.2.1.1 Metallic
5.2.1.2 Ceramic
5.2.1.3 Polymeric Biomaterials
5.2.2 Bone Grafts
5.2.2.1 Allograft
5.2.2.2 Synthetic
5.2.3 Other Products
5.3 Geography
5.3.1 North America
5.3.1.1 Unite States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 Corin Group
6.1.3 DJO Global, Inc. (Enovis)
6.1.4 Depuy Synthes (Johnson & Johnson)
6.1.5 Smith & Nephew
6.1.6 Stryker Corporation
6.1.7 Uteshiya Medicare
6.1.8 Wright Medical Group
6.1.9 Zimmer Biomet Holdings, Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Joint Replacement Industry Segmentation
As per the scope of the report, joint replacement surgery is performed most frequently to replace joints, which involves the complete or partial removal of the damaged joint and tissues, to be replaced with new, man-made parts. The purpose of such a procedure is to relieve pain and restore a sense of normal function and mobility in the damaged joint. These joint replacement surgeries are predominantly suggested for patients undergoing severe pain and disability as a result of progressive arthritis. The devices for joint replacement surgeries include implants, grafts, and all other instruments related to joint replacement procedures. The Joint Replacement Market is Segmented by Procedure (Hip Replacement, Knee Replacement, Shoulder, and Other Procedures), Products (Implants (Metallic, Ceramic, and Polymeric Biomaterials), Bone Grafts (Allografts and Synthetic), and Other Products)), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD) for the above segments.
| By Procedure | |
| Hip Replacement | |
| Knee Replacement | |
| Shoulder | |
| Other Procedures |
| By Products | |||||
| |||||
| |||||
| Other Products |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Joint Replacement Market Research FAQs
How big is the Joint Replacement Market?
The Joint Replacement Market size is expected to reach USD 19.10 billion in 2024 and grow at a CAGR of 4.60% to reach USD 23.70 billion by 2029.
What is the current Joint Replacement Market size?
In 2024, the Joint Replacement Market size is expected to reach USD 19.10 billion.
Who are the key players in Joint Replacement Market?
Stryker Corporation, Zimmer Biomet Holdings, Inc., Depuy Synthes (Johnson & Johnson), Smith & Nephew and Wright Medical Group are the major companies operating in the Joint Replacement Market.
Which is the fastest growing region in Joint Replacement Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Joint Replacement Market?
In 2024, the North America accounts for the largest market share in Joint Replacement Market.
What years does this Joint Replacement Market cover, and what was the market size in 2023?
In 2023, the Joint Replacement Market size was estimated at USD 18.22 billion. The report covers the Joint Replacement Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Joint Replacement Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Joint Replacement Industry Report
Statistics for the 2023 Joint Replacement market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Joint Replacement analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
